Search
for
Sort by
Research 31–60 of 1000+
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- Comparative Efficacy of Oral and Topical 5-Alpha Reductase Inhibitors in Reducing Dihydrotestosterone levels across Men with Androgenetic Alopecia: A Network Meta-Analysis incorporating Post-Hoc Analyses of Randomized Clinical Trial Data
- Depression risk of 5-alpha reductase inhibitors: A systematic review and meta-analysis with a focus on comparator groups
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
- The connection of 5-alpha reductase inhibitors to the development of depression
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement
- Drug-Induced Melasma in Patients on 5-Alpha Reductase Inhibitors: A Case Report
- Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
- Risk of rhabdomyolysis from 5-α reductase inhibitors
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- Editor’s picks January 2021
- Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
- Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis
- The Association Between 5α-Reductase Inhibitors and the Presence of Subsequent Dry Eye Disease in Androgenetic Alopecia: A TriNetX Database Study
- Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy
- IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study
- Differential association between cumulative dose of 5α-reductase inhibitors and mortality
- Benign Prostatic Hyperplasia Pharmacotherapy and Incident Ocular Surface Disease: Comparative Risk of Alpha-Blockers vs 5-Alpha Reductase Inhibitors
- Risk of Poor Glycemic Control in Tamsulosin Versus Finasteride Users with Type 2 Diabetes Mellitus
- Frontal Fibrosing Alopecia in Men: A Review of the Literature
- 5‐alpha‐reductase inhibitor treatment for frontal fibrosing alopecia: an evidence‐based treatment update
- Abstracts from the 2024 WDS Forum - virtual option
- Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments
- Association of Suicidality and Depression With 5α-Reductase Inhibitors